Ensign Peak Advisors
IMGN

Ensign Peak Advisors’s Immunogen Inc IMGN Stock Holding History

Ensign Peak Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-875,868
Closed -$13.9M – 1773
2023
Q3 		$13.9M Buy
875,868
+289,275
+49% +$4.81M 0.03% 326
2023
Q2 		$11.1M Buy
+586,593
New +$6.93M 0.02% 393
2022
Q4 		– Sell
-301,826
Closed -$1.44M – 2290
2022
Q3 		$1.44M Buy
301,826
+261,756
+653% +$1.38M ﹤0.01% 905
2022
Q2 		$180K Hold
40,070
– – ﹤0.01% 1829
2022
Q1 		$191K Buy
40,070
+7,170
+22% +$39.7K ﹤0.01% 1886
2021
Q4 		$244K Buy
+32,900
New +$204K ﹤0.01% 1882

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Ensign Peak Advisors's IMGN Position: Q4 2023 in Review

Ensign Peak Advisors sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 875,868 shares — an estimated $13.9M sold.

Ensign Peak Advisors first reported a position in IMGN in Q4 2021 and held it in 6 quarters. The position peaked at $13.9M in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Ensign Peak Advisors reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Ensign Peak Advisors sold 875,868 Immunogen Inc shares in Q4 2023, an estimated $13.9M.
  • Ensign Peak Advisors first reported a position in Immunogen Inc in Q4 2021 and held it in 6 quarters.
  • Ensign Peak Advisors's Immunogen Inc position peaked at $13.9M in Q3 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Ensign Peak Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.